AGL Antikörper (AA 1479-1510)
Kurzübersicht für AGL Antikörper (AA 1479-1510) (ABIN7870748)
Target
Alle AGL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1479-1510
-
Verwendungszweck
- Glycogen debranching enzyme Antibody / AGL
-
Aufreinigung
- Purified
-
Immunogen
- A portion of amino acids 1479-1510 from the human protein was used as the immunogen for the Glycogen debranching enzyme antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the Glycogen debranching enzyme antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the Glycogen debranching enzyme antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- AGL (Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))
-
Andere Bezeichnung
- Glycogen debranching enzyme
-
Hintergrund
- AGL is a glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in the AGL gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing.
-
UniProt
- P35573
-
Pathways
- Cellular Glucan Metabolic Process
Target
-